Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders

Clinical trial NCT05891379 · UNKNOWN

Trial details

NCT number: NCT05891379
Sponsor: Xuanwu Hospital, Beijing
Status: UNKNOWN
Study type: OBSERVATIONAL

Neuromyelitis Optica Spectrum Disorder

Start date: 2024-07-09
Primary completion: 2025-07-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.